Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Noel Barrett

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Expert Review of Vaccines|February 19, 2013
The need for a new vaccine against lyme borreliosisP Noel Barrett, Daniel Portsmouth
Expert Review of Vaccines|September 24, 2013
A novel multivalent OspA vaccine against Lyme borreliosis shows promise in Phase I/II studiesP Noel Barrett, Daniel Portsmouth
The Lancet. Infectious Diseases|June 25, 2011
Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1)P Noel Barrett, Hartmut J Ehrlich
Expert Review of Vaccines|April 9, 2013
Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical developmentP Noel Barrett, Daniel Portsmouth, Hartmut J Ehrlich
Biological Chemistry|October 28, 2008
Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccinesM Keith Howard, Otfried Kistner, P Noel Barrett
Travel Medicine and Infectious Disease|February 22, 2011
Re: Tick-borne encephalitis (TBE) trends in epidemiology and current and future managementHartmut J Ehrlich, Robert Petermann, P Noel Barrett
Current Opinion in Molecular Therapeutics|February 9, 2010
Developing cell culture-derived pandemic vaccinesP Noel Barrett, Daniel Portsmouth, Hartmut J Ehrlich
Vaccine|March 12, 2003
History of TBE vaccinesP Noel Barrett, Susanne Schober-Bendixen, Hartmut J Ehrlich
Expert Review of Vaccines|April 29, 2009
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccinesP Noel Barrett, Wolfgang Mundt, Otfried Kistner, et al.
The Lancet. Infectious Diseases|December 21, 2013
Lyme disease vaccination: safety first - authors' replyP Noel Barrett, Brian A Crowe, Nina Wressnigg, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Expert Review of Vaccines|February 19, 2013
The need for a new vaccine against lyme borreliosisP Noel Barrett, Daniel Portsmouth
Expert Review of Vaccines|September 24, 2013
A novel multivalent OspA vaccine against Lyme borreliosis shows promise in Phase I/II studiesP Noel Barrett, Daniel Portsmouth
The Lancet. Infectious Diseases|June 25, 2011
Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1)P Noel Barrett, Hartmut J Ehrlich
Expert Review of Vaccines|April 9, 2013
Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical developmentP Noel Barrett, Daniel Portsmouth, Hartmut J Ehrlich
Biological Chemistry|October 28, 2008
Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccinesM Keith Howard, Otfried Kistner, P Noel Barrett
Travel Medicine and Infectious Disease|February 22, 2011
Re: Tick-borne encephalitis (TBE) trends in epidemiology and current and future managementHartmut J Ehrlich, Robert Petermann, P Noel Barrett
Current Opinion in Molecular Therapeutics|February 9, 2010
Developing cell culture-derived pandemic vaccinesP Noel Barrett, Daniel Portsmouth, Hartmut J Ehrlich
Vaccine|March 12, 2003
History of TBE vaccinesP Noel Barrett, Susanne Schober-Bendixen, Hartmut J Ehrlich
Expert Review of Vaccines|April 29, 2009
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccinesP Noel Barrett, Wolfgang Mundt, Otfried Kistner, et al.
The Lancet. Infectious Diseases|December 21, 2013
Lyme disease vaccination: safety first - authors' replyP Noel Barrett, Brian A Crowe, Nina Wressnigg, et al.
Pageof 7